EMBER: A Study of LY3484356 in Patients with Breast or Other Non-Breast Cancers
J2J-MC-JZLA
Phase 1 other active
Quick answer
EMBER: A Study of LY3484356 in Patients with Breast or Other Non-Breast Cancers for Breast Cancer, Endometrial cancer is a Phase 1 program (other) at Eli Lilly Co. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Eli Lilly Co.
- Indication
- Breast Cancer, Endometrial cancer
- Phase
- Phase 1
- Modality
- other
- Status
- active